Viking Therapeutics, Inc. (VKTX)
29.22
+1.64
(+5.95%)
USD |
NASDAQ |
Nov 13, 16:00
29.10
-0.12
(-0.41%)
After-Hours: 19:59
Viking Therapeutics Market Cap : 3.726B for Nov. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 12, 2026 | 3.517B |
| November 11, 2026 | 3.627B |
| November 10, 2026 | 3.655B |
| November 09, 2026 | 3.697B |
| November 06, 2026 | 3.423B |
| November 05, 2026 | 3.289B |
| November 04, 2026 | 3.567B |
| November 03, 2026 | 3.327B |
| November 02, 2026 | 3.421B |
| October 30, 2026 | 3.479B |
| October 29, 2026 | 3.425B |
| October 28, 2026 | 3.234B |
| October 27, 2026 | 3.174B |
| October 26, 2026 | 3.087B |
| October 23, 2026 | 3.112B |
| October 22, 2026 | 3.013B |
| October 21, 2026 | 3.077B |
| October 20, 2026 | 3.116B |
| October 19, 2026 | 2.922B |
| October 16, 2026 | 2.936B |
| October 15, 2026 | 3.193B |
| October 14, 2026 | 2.971B |
| October 13, 2026 | 3.109B |
| October 12, 2026 | 3.306B |
| October 09, 2026 | 3.326B |
| Date | Value |
|---|---|
| October 08, 2026 | 3.235B |
| October 07, 2026 | 3.329B |
| October 06, 2026 | 3.311B |
| October 05, 2026 | 3.416B |
| October 02, 2026 | 3.493B |
| October 01, 2026 | 3.559B |
| September 30, 2026 | 3.803B |
| September 29, 2026 | 3.711B |
| September 28, 2026 | 3.853B |
| September 25, 2026 | 4.148B |
| September 24, 2026 | 4.287B |
| September 23, 2026 | 4.859B |
| September 22, 2026 | 4.765B |
| September 21, 2026 | 3.512B |
| September 18, 2026 | 3.382B |
| September 17, 2026 | 3.425B |
| September 16, 2026 | 3.444B |
| September 15, 2026 | 3.494B |
| September 14, 2026 | 3.678B |
| September 11, 2026 | 3.731B |
| September 10, 2026 | 3.748B |
| September 09, 2026 | 3.815B |
| September 08, 2026 | 3.929B |
| September 04, 2026 | 4.068B |
| September 03, 2026 | 3.964B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 1.360T |
| Ironwood Pharmaceuticals, Inc. | 797.95M |
| Compass Therapeutics, Inc. | 139.05M |
| Amgen, Inc. | 251.83B |
| ACADIA Pharmaceuticals, Inc. | 3.238B |
Market Cap Related Metrics
| PEG Ratio | -0.0349 |
| Price to Book Value | 6.331 |
| Price | 29.22 |
| Earnings Yield | -18.50% |
| PEGY Ratio | -0.0349 |